BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 5, 2001
View Archived Issues
Clash Over Stem Cell Research Delayed As Bush Mulls Options
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE* #
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE#
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS*
Read More
UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2000, TO DEC. 31, 2000: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY AFTER-MARKET PERFORMANCE#
Read More